Kwality Pharmaceuticals Limited (KPL.BO)
INR 868.0
(0.32%)
INR 868.0
(0.32%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 323.08 Million | 413.81 Million | 605.96 Million | 267.05 Million | 61.64 Million | 135.75 Million |
| Net Income | 237.96 Million | 255.72 Million | 1.61 Billion | 212.71 Million | 109.17 Million | 109.1 Million |
| Depreciation & Amortization | 195.58 Million | 149.58 Million | 106.9 Million | 64.93 Million | 44.33 Million | 31.18 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -240.44 Million | 10.14 Million | -731.76 Million | 27.24 Million | -91.28 Million | 8.89 Million |
| Other non-cash items | 829.47 Million | -1.63 Million | -384.84 Million | -37.83 Million | -576 Thousand | -13.42 Million |
| Investing Cash Flow | -265.26 Million | -484.4 Million | -629.27 Million | -232.02 Million | -177.98 Million | -117.83 Million |
| Investments in PPE | -306.37 Million | -476.73 Million | -551.52 Million | -233.99 Million | -207.79 Million | -118.2 Million |
| Acquisitions | 41.11 Million | 18.62 Million | - | 1.44 Million | 28.45 Million | - |
| Investment purchases | - | - | -483 Thousand | -1.28 Million | 2.28 Million | -1.54 Million |
| Sales/Maturities of investments | - | - | - | - | 2.25 Million | - |
| Other Investing Activities | -7.96 Million | -26.3 Million | -77.26 Million | 1.81 Million | -3.19 Million | 1.91 Million |
| Financing Cash Flow | -72.02 Million | 9.94 Million | 56.56 Million | 7.67 Million | 117.71 Million | -20.01 Million |
| Debt repayment | -72.02 Million | -9.94 Million | -123.43 Million | -3.69 Billion | -2.52 Billion | -2.48 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -101.95 Million | 19.88 Million | 179.99 Million | 3.7 Billion | 2.64 Billion | 2.46 Billion |
| Accounts receivables | -426.91 Million | - | -334.19 Million | -53.79 Million | 80.96 Million | -13.94 Million |
| Accounts payables | 91.24 Million | - | 83 Million | 32.49 Million | 58.97 Million | -50.68 Million |
| Inventory | 27.34 Million | -329.54 Million | -359.95 Million | 50.52 Million | -111.69 Million | 37.85 Million |
| Other working capital | 67.87 Million | 339.68 Million | -120.61 Million | -1.97 Million | -119.53 Million | 35.67 Million |
| Cash at beginning of period | 30.69 Million | 91.34 Million | 58.08 Million | 15.38 Million | 14 Million | 16.08 Million |
| Cash at end of period | 59.43 Million | 30.69 Million | 91.34 Million | 58.08 Million | 15.38 Million | 14 Million |
| Capital Expenditure | -306.37 Million | -476.73 Million | -551.52 Million | -233.99 Million | -207.79 Million | -118.2 Million |
| Effect of forex changes on cash | - | - | 1000.00 | - | - | -1000.00 |
| Net cash flow / Change in cash | 28.74 Million | -60.65 Million | 33.26 Million | 42.7 Million | 1.38 Million | -2.08 Million |
| Free Cash Flow | 16.7 Million | -62.91 Million | 54.44 Million | 33.05 Million | -146.14 Million | 17.55 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 237.96 Million | 76.9 Million | 62.35 Million | 54.23 Million | 255.72 Million | -73.78 Million |
| Depreciation & Amortization | 195.58 Million | 48.19 Million | 48.84 Million | 47.87 Million | 149.58 Million | 44.26 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -240.44 Million | - | - | - | 10.14 Million | - |
| Other non-cash items | 829.47 Million | -48.19 Million | -48.84 Million | -47.87 Million | -1.63 Million | -44.26 Million |
| Investing Cash Flow | -265.26 Million | - | - | - | -484.4 Million | - |
| Investments in PPE | -306.37 Million | - | - | - | -476.73 Million | - |
| Acquisitions | 41.11 Million | - | - | - | 18.62 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -7.96 Million | - | - | - | -26.3 Million | - |
| Financing Cash Flow | -72.02 Million | - | - | - | 9.94 Million | - |
| Debt repayment | -72.02 Million | - | - | - | -9.94 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | 19.88 Million | - |
| Accounts receivables | -426.91 Million | - | - | - | - | - |
| Accounts payables | 91.24 Million | - | - | - | - | - |
| Inventory | 27.34 Million | - | - | - | -329.54 Million | - |
| Other working capital | 67.87 Million | - | - | - | 339.68 Million | - |
| Cash at beginning of period | 30.69 Million | 28.97 Million | -33.38 Million | 30.69 Million | 91.34 Million | 104.48 Million |
| Cash at end of period | 59.43 Million | 76.9 Million | 28.97 Million | 54.23 Million | 30.69 Million | 30.69 Million |
| Capital Expenditure | -306.37 Million | - | - | - | -476.73 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 28.74 Million | 47.92 Million | 62.35 Million | 23.53 Million | -60.65 Million | -73.78 Million |
| Free Cash Flow | 16.7 Million | 76.9 Million | 62.35 Million | 54.23 Million | -62.91 Million | -73.78 Million |
VISI
HGH
EXLA
GHI
SOC
ALPM